ETFs TELCON RF PHARMACEUTICAL. Inc.

A200230

KR7200230001

Communications & Networking

End-of-day quote Korea S.E. 2026-09-21			5-day change	1st Jan Change
2,190.00 ^KRW	-0.68%		+1.39%	-76.12%

07-14	TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd.	CI
07-05	TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd.	CI

ETFs positioned on TELCON RF PHARMACEUTICAL. Inc.

Name		YTD change	Weight	AuM
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP ETF - USD		+10.95%	0%	12,001 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD		+16.72%	0%	12,086 M€

TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Companyâ€™s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Employees

126

Sector

Communications & Networking

More about the company